Orthofix International | OFIX - Gross Profit On Sales


Orthofix International reported $153.28M in Gross Profit on Sales for its fiscal quarter ending in December of 2025.





Gross Profit On Sales Change Date
Accuray USD 41.89M 7.42M Dec/2024
AngioDynamics USD 44.78M 2.93M Sep/2025
Artivion USD 73.14M 1.25M Dec/2025
AtriCure USD 109.31M 3.97M Mar/2026
Dexcom USD 750.3M 42.4M Mar/2026
EDAP TMS EUR 8.15M 2.17M Mar/2026
Globus Medical USD 548.17M 51.91M Jun/2026
Inogen USD 41.34M 1.39M Sep/2024
Insulet USD 562.6M 21.8M Jun/2026
Integra LifeSciences USD 215.97M 2.77M Jun/2026
J&J USD 18.55B 6M Sep/2026
Medtronic USD 6.36B 355M Jun/2026
Mesa Laboratories USD 39.75M 4.3M Dec/2024
Orthofix International USD 153.28M 4.76M Dec/2025
Plus Therapeutics 1.37M 30K Dec/2025
Smith & Nephew USD 2.09B 117M Dec/2025
STAAR Surgical USD 69.73M 868K Jun/2026
Stryker USD 4.5B 688M Jun/2026
Tandem Diabetes Care USD 144.78M 7.99M Jun/2026
Teleflex USD 331.71M 24.28M Jun/2026
Veracyte USD 108.55M 7.39M Jun/2026
Zimmer Biomet Holdings USD 1.36B 149.4M Jun/2026